These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 711100)

  • 1. [Behavior of the fasting blood sugar values in diabetics treated with oral and parenteral pentoxifylline].
    Tat H; Marx-Heep I; Adams HJ
    Fortschr Med; 1978 Oct; 96(40):2053-6. PubMed ID: 711100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline (Trental) has no significant effect on laboratory parameters in sickle cell disease.
    Billett HH; Kaul DK; Connel MM; Fabry ME; Nagel RL
    Nouv Rev Fr Hematol (1978); 1989; 31(6):403-7. PubMed ID: 2694097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [When should stable maturity-onset diabetics be switched to insulin?].
    Selz B; Nyffenegger U; Bürgi H
    Schweiz Med Wochenschr; 1980 Oct; 110(42):1534-7. PubMed ID: 7006072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of pentoxifylline on glycometabolic balance in diabetic subjects].
    Ferlito S; Mangiagli P; Di Mauro C
    Clin Ter; 1981 Jun; 97(6):613-8. PubMed ID: 7023805
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes of serum insulin during fasting and glucose loading before and after treatment of diabetes].
    Kosaka K; Hagura R; Ogawara H
    Dtsch Med J; 1970 Apr; 21(8):554-64. PubMed ID: 5510200
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of trental and complamine in the microcirculatory disorders of diabetes mellitus].
    Spesivtseva VG; Kasabian IN; Mamaeva GG; Kukes VG
    Sov Med; 1980; (2):64-9. PubMed ID: 6987747
    [No Abstract]   [Full Text] [Related]  

  • 10. Study on the relation between nocturnal hypoglycemia and fasting blood sugar level in diabetics treated with hypoglycemic agents.
    Yoshizawa K; Ichinose M; Nishitani H; Tanaka M
    Osaka City Med J; 1979; 25(1):1-6. PubMed ID: 545223
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H; Höxter G
    Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood glucose and serum insulin levels following acute and chronic pentoxifylline administration.
    Heidrich H; Schirop T
    Acta Diabetol Lat; 1980; 17(1):15-21. PubMed ID: 6998241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of diabetes mellitus treated with insulin and oral hypoglycemic agents in Denmark.
    Nielsen NV; Hemmingsen L
    Diabetes Res; 1986 Oct; 3(8):423-5. PubMed ID: 3545623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F; Pempinello R; Romis L
    Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of nopal intake upon fasting glycemia in type II diabetics and healthy subjects.
    Frati AC; Gordillo BE; Altamirano P; Ariza CR; Cortés-Franco R; Chávez-Negrete A; Islas-Andrade S
    Arch Invest Med (Mex); 1991; 22(1):51-6. PubMed ID: 1668138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
    Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
    Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood glucose concentrations and glycosuria during and after one year of acarbose therapy.
    Aubell R; Boehme K; Berchtold P
    Arzneimittelforschung; 1983; 33(9):1314-8. PubMed ID: 6357206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral antidiabetic monotherapy and combination treatment with glybenclamide (HB 419) and biguanides of insulin receiving diabetics of the adult type].
    Knick B; Wendt O; Konder ML; Netter P
    Med Klin; 1970 Jan; 65(3):109-12. PubMed ID: 5519048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.